PRESS RELEASE published on 10/14/2024 at 07:30, 20 days 5 hours ago Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique TG4001 dans les cancers du col de l’utérus et anogénitaux HPV16 positifs, récurrents ou métastatiques Transgene présente les résultats préliminaires de l'étude de Phase II du vaccin TG4001 dans les cancers du col de l'utérus HPV16 positifs, montrant une tendance positive malgré le non-atteinte de l'objectif principal Transgene Vaccin Thérapeutique Étude De Phase II Cancer Du Col De L'utérus HPV16
PRESS RELEASE published on 10/14/2024 at 07:30, 20 days 5 hours ago Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers
BRIEF published on 09/14/2024 at 09:10, 1 month 19 days ago Transgene and BioInvent: promising results for the oncolytic virus BT-001 Cancer Transgene Oncolytic Virus BioInvent BT-001
BRIEF published on 09/14/2024 at 09:10, 1 month 19 days ago Transgene et BioInvent : résultats prometteurs pour le virus oncolytique BT-001 Cancer Transgene Virus Oncolytique BioInvent BT-001
PRESS RELEASE published on 09/14/2024 at 09:05, 1 month 19 days ago Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments Transgene and BioInvent present promising early results of oncolytic virus BT-001 in ESMO 2024, showing antitumor activity in solid tumors. BT-001 induces tumor regression and enhances T cell infiltration Transgene Oncolytic Virus BioInvent Antitumor Activity ESMO 2024
PRESS RELEASE published on 09/14/2024 at 09:05, 1 month 19 days ago Le virus oncolytique BT-001 de Transgene et BioInvent montre une activité antitumorale prometteuse dans l’étude en cours de Phase I/IIa dans les tumeurs solides résistantes Le virus oncolytique BT-001 de Transgene et BioInvent montre une activité antitumorale prometteuse dans une étude en cours de Phase I/IIa sur les tumeurs solides résistantes, présentant des premiers signes d'efficacité en combinaison avec KEYTRUDA Étude Clinique Tumeurs Solides Virus Oncolytique BT-001 Activité Antitumorale
BRIEF published on 09/13/2024 at 10:37, 1 month 20 days ago Franchissement de seuil par SITAM Belgique dans TRANSGENE S.A. Droits De Vote Franchissement De Seuil Augmentation De Capital SITAM Belgique TRANSGENE S.A.
BRIEF published on 09/13/2024 at 10:37, 1 month 20 days ago Threshold crossing by SITAM Belgium in TRANSGENE SA Voting Rights Capital Increase Threshold Crossing SITAM Belgium TRANSGENE SA
PRESS RELEASE published on 09/13/2024 at 10:32, 1 month 20 days ago Franchissement de seuil Déclaration de franchissement de seuil de la société TRANSGENE S.A. par SITAM Belgique, détenant 3,65% du capital et 4,85% des droits de vote Déclaration Franchissement De Seuil AMF SITAM Belgique TRANSGENE S.A.
BRIEF published on 09/10/2024 at 07:35, 1 month 23 days ago Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation Cancer Treatment Oncology Leadership Immunotherapy Transgene
Published on 11/03/2024 at 00:45, 12 hours 44 minutes ago Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 18 hours 14 minutes ago Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours 19 minutes ago Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 59 minutes ago Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company
Published on 11/01/2024 at 21:31, 1 day 15 hours ago Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 19 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 20 hours ago EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 10/31/2024 at 18:19, 2 days 19 hours ago Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 19 hours ago Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%